Search
Mesothelioma Treatment Options Asbestos Exposure News Veterans And Mesothelioma About ELSS FREE Case Evaluation Top Mesothelioma Doctors

H. Ian Robins, M.D.
Dr. H. Ian Robins is chairman of the Systemic Hypothermia Oncological working group at the University of Wisconsin Hospital and Clinics specializing in malignant mesothelioma.

Mark Lischner, M.D.
Dr. Mark Lischner works as a physician with the Sutter Physician Alliance in Roseville, California specializing in pulmonary diseases including mesothelioma.

This website is certified by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information:
verify here.

Free Mesothelioma Information Packet

Enter your information to receive a comprehensive mesothelioma packet free of charge at your doorstep within 24 hours.

Yes   No

Clinical Trials

Centerwatch -
Find out about current clinical trials near you for mesothelioma treatment.

National Cancer Institute -
Search for clinical trials listed at NCI

Studies of promising new or experimental treatments in patients are known as clinical trials. During a course of treatment for lung cancer, the doctor may suggest that a patient take part in a clinical trial of a new treatment. A clinical trial is only done when there is some reason to believe that the treatment being studied may be of value to the patient. Treatments used in clinical trials are often found to have real benefits.

There are three phases of clinical trials in which a treatment is studied before the treatment is eligible for approval by the FDA (Food and Drug Administration).

The purpose of a Phase I study is to find the best way to give a new treatment and how much of it can be given safely. Physicians watch patients carefully for any harmful side effects. The research treatment has been well tested in laboratory and animal studies, but the side effects in patients are not completely predictable.

Phase II trials determine the effectiveness of a research treatment after safety has been evaluated in a Phase I trial. Patients are closely observed for an anticancer effect by careful measurement of cancer sites present at the beginning of the trial. In addition to monitoring patients for response, any side effects are carefully recorded and assessed.

Phase III trials require entry of large numbers of patients; some trials enroll thousands of patients. One of the groups may receive standard (the most accepted) treatment, so the new treatments can be directly compared. The group that receives the standard treatment is called the "control group. " For example, one group of patients (the control group) may receive the standard chemotherapy for a certain type of cancer, while another patient group may receive another type of chemotherapy that may or may not contain an investigational drug to see if this improves survival. All patients in Phase III trials are monitored closely for side effects, and treatment is discontinued if the side effects are too severe.

Researchers conduct studies of new treatments to answer the following questions:

However, there are some risks. No one involved in the study knows in advance whether the treatment will work or exactly what side effects will occur. That is what the study is designed to discover. While most side effects will disappear in time, some can be permanent or even life-threatening. Keep in mind, though, that even standard treatments have side effects. Depending on many factors, you may decide that a clinical trial may be beneficial in your case.

Enrollment in any clinical trial is completely up to you. Your doctors and nurses will explain the study to you in detail and will give you a form to read and sign indicating your desire to take part. This process is known as giving your informed consent. Even after signing the form and after the clinical trial begins, you are free to leave the study at any time, for any reason. Taking part in the study does not prevent you from getting other medical care you may need.

To find out more about clinical trials, ask your cancer care team. Among the questions you should ask are:

Source

National Cancer Institute - Mesothelioma Trial Results
http://www.cancer.gov/clinicaltrials/results/mesothelioma

If you have any questions regarding treatment options or your legal rights, please contact us.